This was the stock's second consecutive day of losses.

Shares of Elevance Health Inc. ELV slid 1.66% to $421.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.74% to 5,525.21 ...

Argus raised the firm’s price target on Elevance Health (ELV) to $465 from $450 and keeps a Buy rating on the shares. The company’s results ...

Seeing your biggest competitor fail is the next best thing to achieving success yourself. That’s the story of Elevance Health ...

The program now serves 6 million patients, and Elevance sees it as something that sets it apart from the competition.